van Erp, Inge A. M. http://orcid.org/0000-0003-3472-0367
van Essen, Thomas A.
Fluiter, Kees
van Zwet, Erik
van Vliet, Peter
Baas, Frank
Haitsma, Iain
Verbaan, Dagmar
Coert, Bert
de Ruiter, Godard C. W.
Moojen, Wouter A.
van der Jagt, Mathieu
Peul, Wilco C.
Funding for this research was provided by:
Hersenstichting (DR-2019-00292)
Takeda Pharmaceuticals U.S.A. (IIR-NLD-002790)
Article History
Received: 22 April 2021
Accepted: 15 November 2021
First Online: 4 December 2021
Declarations
:
: Approval of the Medical Ethics Committee (METC-LDD) and the Scientific Research Committee from the department Neurosurgery of Leiden University Medical Center has been granted on 23/07/2020. The submitted protocol was reviewed under reference number P20.021. Subsequent approval by local committees from participating centers has been/will be obtained according to local regulations. Important protocol amendments will be communicated to relevant parties. Written informed consent, proxy consent, or deferred consent is applicable for this trial.
: Not applicable.
: WP reports to be part of the management team of the CENTER-TBI study (NCT02210221) and to be the principal investigator of the Net-Qure (NL5761), RESET-ASDH, and SPARTA trials. All other authors declare that they have no competing interests.